Stock Research for LXRP

LXRP

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

LXRP Stock Chart & Research Data

The LXRP chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the LXRP chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


LXRP Due diligence Resources & Stock Charts

The LXRP stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View LXRP Detailed Price Forecast - CNN Money CNN View LXRP Detailed Summary - Google Finance
Yahoo View LXRP Detailed Summary - Yahoo! Finance Zacks View LXRP Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View LXRP Trends & Analysis - Trade-Ideas Barrons View LXRP Major Holders - Barrons
NASDAQ View LXRP Call Transcripts - NASDAQ Seeking View LXRP Breaking News & Analysis - Seeking Alpha
Spotlight View LXRP Annual Report - CompanySpotlight.com OTC Report View LXRP OTC Short Report - OTCShortReport.com
TradeKing View LXRP Fundamentals - TradeKing Charts View LXRP SEC Filings - Bar Chart
WSJ View Historical Prices for LXRP - The WSJ Morningstar View Performance/Total Return for LXRP - Morningstar
MarketWatch View the Analyst Estimates for LXRP - MarketWatch CNBC View the Earnings History for LXRP - CNBC
StockMarketWatch View the LXRP Earnings - StockMarketWatch MacroAxis View LXRP Buy or Sell Recommendations - MacroAxis
Bullish View the LXRP Bullish Patterns - American Bulls Short Pains View LXRP Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View LXRP Stock Mentions - StockTwits PennyStocks View LXRP Stock Mentions - PennyStockTweets
Twitter View LXRP Stock Mentions - Twitter Invest Hub View LXRP Investment Forum News - Investor Hub
Yahoo View LXRP Stock Mentions - Yahoo! Message Board Seeking Alpha View LXRP Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for LXRP - SECform4.com Insider Cow View Insider Transactions for LXRP - Insider Cow
CNBC View LXRP Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for LXRP - OTC Markets
Yahoo View Insider Transactions for LXRP - Yahoo! Finance NASDAQ View Institutional Holdings for LXRP - NASDAQ


Stock Charts

FinViz View LXRP Stock Insight & Charts - FinViz.com StockCharts View LXRP Investment Charts - StockCharts.com
BarChart View LXRP Stock Overview & Charts - BarChart Trading View View LXRP User Generated Charts - Trading View




Latest Financial News for LXRP


More Companies Lining Up to Get Their Hands on Lexarias DehydraTECH Platform -- CFN Media
Posted on Thursday August 15, 2019

Seattle, Washington--(Newsfile Corp. - August 15, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an article discussing Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and its DehydraTECH™ technology.When you've got something great, it may take a little bit of time for people to learn about it, but once word starts getting around, it can yield a windfall of ...


Lexaria Bioscience Announces it has Received Four New Patents
Posted on Thursday August 15, 2019

KELOWNA, BC / ACCESSWIRE / August 15, 2019 / Lexaria Bioscience Corp. (LXRP) (LXX.CN) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce that four of its pending patent applications, via its wholly-owned subsidiary Poviva Corp., have now been granted.


Lexaria’s Appoints Former Altria Group Senior Executive and Operating Company Chief to Board of Directors
Posted on Wednesday August 14, 2019

KELOWNA, BC / ACCESSWIRE / August 14, 2019 / Lexaria Bioscience Corp. (LXRP) (LXX.CN) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Brian Quigley to its board of directors. Mr. Quigley most recently spent 16 years at Altria Group, with 7 of those years spent as President and Chief Executive Officer for U.S. Smokeless Tobacco and Nu-Mark, Altria's innovation company, during the time that the existing business relationship between Altria and Lexaria was negotiated. Mr. Quigley is a 20-year Consumer Packaged Goods veteran of managing complex regulatory environments including for novel and innovative nicotine products, with additional deep experience with operations and marketing.


Lexaria Bioscience Receives Cannabis R&D License from Health Canada
Posted on Tuesday August 13, 2019

KELOWNA, BC / ACCESSWIRE / August 13, 2019 / Lexaria Bioscience Corp. (LXRP) (LXX.CN) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce that its subsidiary, Lexaria CanPharm ULC., has been issued cannabis Research and Development (“R&D”) license LIC-7NONT76UNW-2019 by Health Canada with a four-year term until August 9, 2023 unless renewed. Lexaria’s new cannabis R&D license is effective immediately and will allow one of the country’s newest and most advanced formulation laboratories to conduct extensive investigatory work in both THC and CBD delivery using proprietary, optimized formulations and techniques. The laboratory was purpose-built, is permitted at local and federal levels, fully outfitted with equipment required to produce DehydraTECHTM infusions as well as including two different methodologies by which the Company can create nano-sized molecules when deemed beneficial and is currently operational.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.